Download:
pdf |
pdfOMB No. 3117‐0016/USITC No. 20‐3‐4295; Expiration Date: 6/30/2023
(No response is required if currently valid OMB control number is not displayed)
LOST SALES AND LOST REVENUE SURVEY
METHIONINE FROM FRANCE, JAPAN, AND SPAIN
This survey must be received by the Commission by August 12, 2020
See last page for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its antidumping investigations concerning methionine from France, Japan, and Spain (Inv. Nos. 731‐TA‐
1534‐1536 (Preliminary)). The information requested in the survey is requested under the authority of the Tariff Act of
1930, title VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to compel
the submission of records or information in your possession (19 U.S.C. § 1333(a)). Further information on this survey can
be obtained from Craig Thomsen ([email protected], (202) 205‐3226).
Name of firm
Address
City
State
Zip Code
Website
Has your firm purchased ‐ or imported for its own use or retail sale ‐ methionine (as defined on next page) at any
time since January 1, 2017?
NO
(Sign the certification below and promptly return only this page of the survey to the Commission)
YES
(Complete all parts of the survey, and return the entire survey to the Commission)
Return questionnaire via the U.S. International Trade Commission Drop Box by clicking on the
following link: https://dropbox.usitc.gov/oinv/. (PIN: MET)
CERTIFICATION
I certify that the information herein supplied in this survey is complete and correct to the best of my knowledge and belief and
understand that the information submitted is subject to audit and verification by the Commission. By submitting this certification I
also grant consent for the Commission, and its employees and contract personnel, to use the information provided in this survey
and throughout this proceeding in any other import‐injury proceedings conducted by the Commission on the same or similar
merchandise.
I, the undersigned, acknowledge that information submitted in response to this request for information and throughout this
investigation or other proceeding may be disclosed to and used: (i) by the Commission, its employees and Offices, and contract
personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits,
reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. I understand that all
contract personnel will sign appropriate nondisclosure agreements.
Name of Authorized Official Title of Authorized Official
Date
Signature
Phone
Email address
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 2
GENERAL INFORMATION
Background.‐‐This proceeding was instituted in response to a petition filed on July 29, 2020, by Novus
International, Inc., St. Charles, Missouri. Antidumping duties may be assessed on the subject imports as
a result of these proceedings if the Commission makes an affirmative determination of injury, threat, or
material retardation, and if the U.S. Department of Commerce (“Commerce”) makes an affirmative
determination of dumping. Questionnaires and other information pertinent to this proceeding are
available at
https://www.usitc.gov/investigations/701731/2020/methionine_france_japan_and_spain/preliminary.h
tm.
Methionine covered by these investigations is methionine and precursors to methionine, including DL‐
Hydroxy analogue of DL‐methionine, also known as 2‐Hydroxy 4‐(Methylthio) Butanoic acid (HMTBa),
regardless of purity, particle size, grade, or physical form. Methionine has the chemical formula
C5H11NO2S, liquid HMTBa has the chemical formula C5H10O3S, and dry HMTBa has the chemical formula
C6H9CaO5S. Subject merchandise also includes methionine processed in a third country including, but not
limited to, refining or any other processing that would not otherwise remove the merchandise from the
scope of this investigation if performed in the country of manufacture of the in‐scope methionine or
precursors of methionine. Methionine that is otherwise subject to this investigation is not excluded
when commingled (i.e., mixed or combined) with methionine from sources not subject to this
investigation. Only the subject component of such commingled products is covered by the scope of
these investigations.
Methionine is currently imported under statistical reporting numbers 2930.40.00 and 2930.90.46 of the
Harmonized Tariff Schedule of the United States (HTSUS). Methionine has the Chemical Abstracts
Service (CAS) registry numbers 583‐91‐5, 4857‐44‐7, 59‐51‐8 and 922‐50‐9. While the HTSUS
subheadings and CAS registry number are provided for convenience and customs purposes, the written
description of the scope of this investigation is dispositive.
Unit.‐‐Unless otherwise stated, all quantity data are to be reported in short tons dry weight.
Reporting of information.‐‐ If information is not readily available from your records, provide carefully
prepared estimates.
Confidentiality.‐‐The data furnished in response to this survey that reveal the individual operations of
your firm will be treated as confidential by the Commission to the extent that such data are not
otherwise available to the public and will not be disclosed except as may be required by law (see 19
U.S.C. 1677f). Such confidential information will not be published in a manner that will reveal the
individual operations of your firm; however, general characterizations of numerical business proprietary
information (such as discussion of trends) will be treated as confidential business information only at the
request of the submitter for good cause shown.
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 3
Release of information.‐‐The information provided by your firm in response to this survey, as well as
any other business proprietary information submitted by your firm to the Commission in connection
with this proceeding, may become subject to, and released under, the administrative protective order
provisions of the Tariff Act of 1930 (19 U.S.C. § 1677f) and section 207.7 of the Commission’s Rules of
Practice and Procedure (19 CFR § 207.7). This means that certain lawyers and other authorized
individuals may temporarily be given access to the information for use in connection with this
proceeding or other import‐injury proceedings conducted by the Commission on the same or similar
merchandise; those individuals would be subject to severe penalties if the information were divulged to
unauthorized individuals. Please also retain a copy of the final document that you submit.
Contact information.‐‐Please identify the responsible individual and the manner by which Commission
staff may contact that individual regarding the confidential information submitted in this survey. This
may or may not be the person whose signature is at the bottom of page 1.
Name
Title
Email
Telephone
Firms operating more than one establishment should combine the data for all establishments into a
single response.
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 4
PURCHASE INFORMATION
1. Purchases and imports.— Report separately your firm’s domestic purchases and imports of
methionine.
“Purchase” – Purchase from a U.S. entity such as a U.S. producer, a U.S. importer, or other U.S.
firm.
“Import” – Purchase directly from a foreign supplier and your firm is the importer of record.
2017
2018
2019
Item
Purchases of methionine produced in—
United States
Quantity (in short tons dry weight)
France
Japan
Spain
1
Sources unknown
0
0
0
0
0
0
All other countries
2
Total purchases
Imports of methionine from—
France
Japan
Spain
1
All other countries
Total imports3
1
Please identify these countries:
Please indicate the firm(s) from which you purchased this merchandise:
3
If your firm imported methionine at any time since January 1, 2017, please also complete and
return a U.S. importers' questionnaire in this proceeding.
2
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 5
2. Changes in purchasing patterns.—Please indicate how the shares of your firm’s purchases of
methionine from different sources have changed since January 1, 2017.
Source of
purchases
Did not
purchase Decreased Increased Constant Fluctuated
Explanation for trend
United States
France
Japan
Spain
All other
countries
Sources
unknown
3. Major purchasing factors.‐‐Please list, in order of their importance, the main factors your firm
considers in deciding from whom to purchase methionine.
1.
2.
3.
Please list any other factors that are very important in your purchase decisions:
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
4. Activity level.‐‐
(a) Is activity level considered in price determinations for methionine?
No
Yes
Page 6
If yes, please explain.
(a) How frequently are you able to switch between forms of methionine (dry or liquid) or activity
levels?
Always
Frequently
Sometimes
Infrequently
Never
Form
Activity level
Explain
5. Purchasing subject imports rather than domestic products.—
(a)
Since January 2017, did your firm import and/or purchase imports of methionine from
France, Japan, and/or Spain instead of purchasing U.S.‐produced methionine? Respond
for each subject country.
No
Yes
(If “No” for all countries, skip to next
Source
(also respond to parts (b) and (c))
question)
France
Japan
Spain
(b)
If you responded “Yes” to part (a), was the imported product priced lower than the
domestic product?
Source
Yes
No
France
Japan
Spain
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 7
5. Purchasing subject imports rather than domestic products.— Continued.
(c)
If you responded “Yes” to part (a), was price a primary reason for importing and/or
purchasing subject imports rather than domestic product?
If Yes, estimate the quantity
If No, please indicate the
of imports purchased and/or
reason your firm imported
No
Source
Yes imported instead of domestic
and/or purchased imports
product since January 2017
instead of domestic product
(in short tons dry weight)
France
Japan
Spain
6. U.S. producers and import competition.—
(a)
Since January 1, 2017, in connection with a sale or offer to sell methionine to your firm,
did U.S. producers reduce their prices of domestically produced methionine in order to
compete with lower‐priced imports of methionine from the subject countries? Respond
for each subject country.
Yes (also respond to
No (If “No” for all countries,
Source
question part (b))
skip to next question)
Don’t know
(b)
France
Japan
Spain
If your firm responded “yes” to any of the above countries, please provide an estimate
of the reduction in U.S. producers’ prices, and any additional explanations, such as
timing (e.g., months/years), frequency of price reductions, or other market/competitive
factors.
Source
Estimated
reduction in U.S.
prices
(percent)
France
%
Japan
%
Spain
%
Additional explanation, including such information as
timing (e.g., months/years), frequency of price
reductions, or other market/competitive factors
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
7. Other explanations‐‐Please provide any additional comments in this box.
Page 8
8. Stock symbol information.‐‐ If your firm or parent firm is publicly traded, please specify the stock
exchange and trading symbol: .
9. External counsel.‐‐ If your firm or parent firm is represented by external counsel in relation to this
proceeding, please specify the name of the law firm and the lead attorney(s).
Law firm:
Lead attorney(s):
Business Proprietary
Lost Sales and Lost Revenue Survey‐ Methionine (Preliminary)
Page 9
OMB INFORMATION
10. OMB statistics.‐‐Please report the actual number of hours required and the cost to your firm of
completing this survey.
Hours
Dollars
The questions in this survey have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited
as possible. Public reporting burden for this survey is estimated to average 4 hours per response,
including the time for reviewing instructions, gathering data, and completing and reviewing the
survey.
We welcome comments regarding the accuracy of this burden estimate, suggestions for reducing
the burden, and any suggestions for improving this survey. Please attach such comments to your
response or send to the Office of Investigations, USITC, 500 E St. SW, Washington, DC 20436.
HOW TO FILE YOUR SURVEY RESPONSE
Please do not attempt to modify the format or permissions of the survey document.
Please submit the completed survey using one of the methods noted below. If your firm
is unable to complete the MS Word survey or cannot use one of the electronic methods
of submission, please contact the Commission for further instructions.
• Upload via Secure Drop Box.—Upload the MS Word survey along with a scanned copy of the signed
certification page (page 1) through the Commission’s secure upload facility:
Web address: https://dropbox.usitc.gov/oinv/
Pin: MET
• E‐mail.—E‐mail the MS Word survey to [email protected]; include a scanned copy of the
signed certification page (page 1). Submitters are strongly encouraged to encrypt nonpublic documents
that are electronically transmitted to the Commission to protect your sensitive information from
unauthorized disclosure. The USITC secure drop‐box system and the Electronic Document Information
System (EDIS) use Federal Information Processing Standards (FIPS) 140‐2 cryptographic algorithms to
encrypt data in transit. Submitting your nonpublic documents by a means that does not use these
encryption algorithms (such as by email) may subject your firm’s nonpublic information to unauthorized
disclosure during transmission. If you choose a non‐encrypted method of electronic transmission, the
Commission warns you that the risk of such possible unauthorized disclosure is assumed by you and not
by the Commission.
If your firm did not purchase this product, please fill out page 1, print, sign, and submit a scanned copy
to the Commission.
File Type | application/pdf |
File Title | Microsoft Word - Methionine (P)--LSLR questionnaire |
Author | ahdia.bavari |
File Modified | 2020-07-31 |
File Created | 2020-07-31 |